Stein Holst Annexstad
Vorstandsvorsitzender bei Holstein AS
Profil
Stein Holst Annexstad is the founder of Norgesinvest AS (1996),.
NorgesInvestor Value AS (1996), and NorgesInvestor Formuesforvaltning AS (2004).
He is currently the Chief Executive Officer & Director of Holstein AS, and Chairman of.
Agenda Kaupang AS and Norsk Medisinsk Syklotronsenter AS.
His former positions include Deputy Chief Executive Officer of Hafslund Nycomed AS, Chairman of Algeta ASA (2000-2012), Chairman of Mole Genetics AS, Chairman of Investinor AS, Chairman of BerGenBio ASA (2017-2019), Director of Hartvig Wennberg AS, Managing Director of Nycomed ASA, and Director of Bio Medisinsk Innovasjon AS.
Mr. Annexstad received his undergraduate degree from the Norwegian School of Economics & Business Administration in 1969.
Aktive Positionen von Stein Holst Annexstad
| Unternehmen | Position | Beginn |
|---|---|---|
Holstein AS
 Holstein AS Financial ConglomeratesFinance Holstein AS engages in the production, trade, investment, and consultancy services. It is also involved in financing and shipping activities. The company was founded on April 26, 1990 and is headquartered in Asker, Norway. | Vorstandsvorsitzender | - |
| Agenda Kaupang AS | Vorsitzender | - |
| Norsk Medisinsk Syklotronsenter AS | Vorsitzender | - |
Ehemalige bekannte Positionen von Stein Holst Annexstad
| Unternehmen | Position | Ende |
|---|---|---|
| BERGENBIO ASA | Vorsitzender | 13.03.2019 |
NorgesInvestor Formuesforvaltning AS
 NorgesInvestor Formuesforvaltning AS Investment ManagersFinance NorgesInvestor Formuesforvaltning AS is a group of companies that focuses on strategic and financial value development. The private company's investment arm, NorgesInvestor Proto, invests in companies listed on the Oslo Stock Exchange. The company is based in Oslo, Norway. and has subsidiaries in Norway and Sweden. The Norwegian company was founded in 1996 by Jan Gunnar Hartvig, Stein Holst Annexstad. The CEO is Øivind E. Hermansen. | Gründer | 25.01.2006 |
NorgesInvestor Value AS
 NorgesInvestor Value AS Financial ConglomeratesFinance NorgesInvestor Value AS operates as asset management group that focuses on creating strategic and financial values for institutional and private clients. Its business includes wealth management, investments in listed securities, and private equity secondaries. The company was founded by Stein Holst Annexstad, Jan Gunnar Hartvig, and Trond Erik Wennberg in 1996 and is headquartered in Oslo, Norway. | Gründer | - |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Vorsitzender | - |
| Norgesinvest AS | Gründer | - |
Ausbildung von Stein Holst Annexstad
| Norwegian School of Economics & Business Administration | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BERGENBIO ASA | Health Technology |
| Private Unternehmen | 13 |
|---|---|
NorgesInvestor Formuesforvaltning AS
NorgesInvestor Formuesforvaltning AS Investment ManagersFinance NorgesInvestor Formuesforvaltning AS is a group of companies that focuses on strategic and financial value development. The private company's investment arm, NorgesInvestor Proto, invests in companies listed on the Oslo Stock Exchange. The company is based in Oslo, Norway. and has subsidiaries in Norway and Sweden. The Norwegian company was founded in 1996 by Jan Gunnar Hartvig, Stein Holst Annexstad. The CEO is Øivind E. Hermansen. | Finance |
| Hafslund Nycomed AS | Health Technology |
Hartvig Wennberg AS
 Hartvig Wennberg AS Financial ConglomeratesFinance Hartvig Wennberg AS provides asset management services. It offers equity and fixed interest investment services. The company was founded on March 22, 1996 and is headquartered in Oslo, Norway. | Finance |
| Nycomed ASA | Health Technology |
Holstein AS
Holstein AS Financial ConglomeratesFinance Holstein AS engages in the production, trade, investment, and consultancy services. It is also involved in financing and shipping activities. The company was founded on April 26, 1990 and is headquartered in Asker, Norway. | Finance |
Mole Genetics AS
 Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Health Technology |
Bio Medisinsk Innovasjon AS
 Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Bio-Medisinsk Innovasjon AS engages in the development of biotechnology, bio-medical and pharmaceutical businesses. The firm acts as an investor and incubator for start-ups. The company was founded in 2004 and is headquartered in Oslo, Norway. | Health Technology |
Investinor AS
Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Finance |
| Norsk Medisinsk Syklotronsenter AS | |
| Norgesinvest AS | |
NorgesInvestor Value AS
NorgesInvestor Value AS Financial ConglomeratesFinance NorgesInvestor Value AS operates as asset management group that focuses on creating strategic and financial values for institutional and private clients. Its business includes wealth management, investments in listed securities, and private equity secondaries. The company was founded by Stein Holst Annexstad, Jan Gunnar Hartvig, and Trond Erik Wennberg in 1996 and is headquartered in Oslo, Norway. | Finance |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
| Agenda Kaupang AS |
